SCHEMBL7825014

SCHEMBL7825014

COc1nc2cc(Cl)c(Cl)c(Cn3ccc(CCCl)n3)c2nc1OC

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7810677 0.83
SCHEMBL8784394 0.81 HRH4 (0.35)
SCHEMBL8647402 0.77 PTGES (0.30)
SCHEMBL7810607 0.74 CYP19A1 (0.41)
SCHEMBL8784365 0.71 HRH4 (0.34)
SCHEMBL7466499 0.70 HRH4 (0.35)
SCHEMBL7820148 0.70
SCHEMBL8649343 0.69 HRH4 (0.37)
SCHEMBL7819812 0.69 GBA1 (0.33)
SCHEMBL8784616 0.69 TLR8 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0781279-B1 QUINOXALINEDIONE NMDA RECEPTOR ANTAGONISTS PFIZER LTD (GB) 2001-06-13 EP disclosed
US-5783572-A TREATMENT OF NEURODEGENERATIVE DISORDERS PFIZER INC. (US) 1998-07-21 US disclosed
EP-0781279-A1 QUINOXALINEDIONE NMDA RECEPTOR ANTAGONISTS Pfizer Limited (GB) 1997-07-02 EP disclosed
WO-1996008485-A1 QUINOXALINEDIONE NMDA RECEPTOR ANTAGONISTS PFIZER LIMITED (GB) 1996-03-21 WO disclosed